This chapter will focus on the influence of target organ damage, particularly of left ventricular hypertrophy and subclinical kidney dysfunction, in the choice of ACEIs or ARBs therapy in patients with hypertension and heart failure.
CITATION STYLE
Spoletini, I. A., Vitale, C. A., & Rosano, G. M. C. (2015). Target organ damage and RAAS blockade. In ACEi and ARBS in Hypertension and Heart Failure (pp. 119–148). Springer International Publishing. https://doi.org/10.1007/978-3-319-09788-6_4
Mendeley helps you to discover research relevant for your work.